CYC

DRUG3 trials

Sponsors

Italian Sarcoma Group, Chinese SLE Treatment And Research Group, First Affiliated Hospital of Fujian Medical University

Conditions

Ewing's Sarcoma (ES)Prostate CATakayasu Arteritis

Phase 1

Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer

RecruitingNCT07056790

First Affiliated Hospital of Fujian Medical UniversityProstate CA

Start: 2025-05-15End: 2027-05-31Target: 40Updated: 2025-07-09

Phase 2

Protocol for the Treatment of Metastatic Ewing Sarcoma

CompletedNCT02727387

Italian Sarcoma GroupEwing's Sarcoma (ES)

Start: 2009-06-01End: 2022-04-29Updated: 2022-09-19

Phase 3

Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis

CompletedNCT03096275

Chinese SLE Treatment And Research GroupTakayasu Arteritis

Start: 2017-03-16End: 2022-11-11Updated: 2023-08-30

Related Papers

Maintenance therapy with oral cyclophosphamide plus celecoxib in patients with metastatic Ewing sarcoma: Results of the Italian Sarcoma Group/AIEOP EW-2 study.

Journal of Clinical Oncology2020-05-205 citations

Activity of front-line window therapy with temozolomide plus irinotecan in patients with primary multifocal Ewing sarcoma: ISG/AIEOP EW-2 protocol.

Journal of Clinical Oncology2020-05-20